Respiratory Syncytial Virus Vaccine Status Update

A review of RSV burden of disease, changes seen in the 2021 season, barriers to vaccine development, and summary of vaccine candidates currently in phase three clinical trial.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.